Related Experiment Video
Updated: Jul 16, 2026

08:01
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Vascular functions of the plasminogen activation system
William P Fay1, Nadish Garg, Madhavi Sunkar
1Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO 65212, USA. fayw@missouri.edu
Arteriosclerosis, Thrombosis, and Vascular Biology
|March 24, 2007
Summary
Genetically modified mice are crucial for studying the plasminogen activator (PA) system
Area of Science:
- Biochemistry and Molecular Biology
- Vascular Biology
- Genetics
Background:
- The plasminogen activator (PA) system regulates key biological processes like hemostasis and thrombosis.
- Its components' roles in various diseases are under continuous investigation.
- Molecular genetics has established the laboratory mouse as a vital model for studying the PA system.
Purpose of the Study:
- To review studies utilizing genetically modified mice to investigate PA system functions.
- Focus on roles in hemostasis, thrombosis, intimal hyperplasia, and atherosclerosis.
- Emphasize the vascular functions of PA inhibitor-1 and its role in vascular remodeling.
Main Methods:
- Review of studies employing genetically modified mouse models.
- Analysis of data related to hemostasis, thrombosis, and vascular remodeling.
- Examination of PA inhibitor-1's complex regulatory mechanisms.
Main Results:
- Genetically modified mice have elucidated the PA system's roles in vascular health and disease.
- PA inhibitor-1's function in vascular remodeling is multifaceted and influenced by various factors.
- Mouse models provide insights into human vascular disease processes.
Conclusions:
- Genetically modified mice are indispensable tools for understanding the PA system's vascular functions.
- PA inhibitor-1's role in vascular remodeling is complex and warrants further research.
- Mouse models offer valuable, albeit with limitations, platforms for studying human vascular diseases.
More Related Videos
Related Concept Videos
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

